Skip to main content
Clinical Journal of the American Society of Nephrology : CJASN logoLink to Clinical Journal of the American Society of Nephrology : CJASN
. 2019 Mar 18;14(4):586. doi: 10.2215/CJN.01680219

Correction

PMCID: PMC6450357  PMID: 30885912

William F. Pendergraft, Leal C. Herlitz, Denyse Thornley-Brown, Mitchell Rosner, John L. Niles: Nephrotoxic effects of common and emerging drugs of abuse. Clin J Am Soc Nephrol 9: 1996–2005, 2014.

Because of author error, a correction has been issued for the above referenced article. In the section below, the bolded word should be “raise,” instead of “reduce.”

“In general, therapy for acute ecstasy-induced adverse events relies on supportive care, including aggressive cooling, correction of electrolytes, and intravenous fluids. Treatment of severe, symptomatic hyponatremia is a medical emergency, and 100–200 ml of 3% saline should be administered as soon as possible. The goal is to reduce the serum sodium concentration by 3–5 mEq/L, which should acutely lower intracranial pressure and improve symptoms (63).”

Footnotes

Published online ahead of print. Publication date available at www.cjasn.org.


Articles from Clinical Journal of the American Society of Nephrology : CJASN are provided here courtesy of American Society of Nephrology

RESOURCES